![]() |
|
|




U.S. Department of Agriculture, Agriculture Research Service, Arkansas Childrens Nutrition Center, Little Rock, AR 72202;
* Analytical and Applied Sciences Group, Mars Incorporated, Hackettstown, NJ 07840; and
U.S. Department of Agriculture, Agricultural Research Service, Beltsville Human Nutrition Center, Nutrient Data Laboratory, Beltsville, MD 20705
3To whom correspondence should be addressed. E-mail: PriorRonaldL{at}uams.edu.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: catechin proanthocyanidins tannins foods infant foods
Proanthocyanidins (PAs),4 better known as condensed tannins, are oligomeric and polymeric flavan-3-ols. They are ubiquitous and present as the second most abundant natural phenolic after lignin. The flavan-3-ol units are linked mainly through the C4
C8 bond, but the C4
C6 bond also exists (both called B-type). The flavan-3-ol units can also be doubly linked by an additional ether bond between C2
O7 (A-type). The size of PA molecules can be described by their degree of polymerization (DP) (1). Three common flavan-3-ols, which differ in their hydroxylation patterns, are found in PAs. The PAs consisting exclusively of (epi)catechin are procyanidins (PCs). PAs containing (epi)afzelechin or (epi) gallocatechin as subunits are named propelargonidins (PPs) or prodelphinidins (PDs), respectively. PPs and PDs are less common in nature than PCs. They are heterogeneous in their constituent units and coexist with the PCs (1).
PAs are of great interest in nutrition and medicine because of their potent antioxidant capacity and possible protective effects on human health (2). PAs have been suggested to account for a significant fraction of polyphenols ingested in a Western diet because of their ubiquitous existence (2). There have been many studies concerning the content of flavonoids in foods and their daily intake (37). However, no data exist concerning the daily intake of oligomeric and polymeric flavan-3-ols because data are lacking on the PA content of foods, in particular. Only recently has an appropriate analytical method been developed for the measurement of PAs (8,9). The objective of the present study was to quantitatively analyze PAs in both common and infant foods and evaluate their daily intake in the U.S. population on the basis of food consumption survey data. This study will establish a PA food database under the USDA National Food and Nutrition Analysis Program.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Food samples. Foods were sampled from four areas of the United States in two seasons. The samples were colleted and processed in the Department of Biochemistry of Virginia Technical University (Blacksburg, VA). Sorghum samples were provided by Dr. Lloyd Rooney (Texas A&M, College Station, TX). Samples were shipped frozen on dry ice and kept at -70°C before use. The fruits and vegetables were received in the form of freeze-dried powders. The final data were converted to a fresh weight basis using the moisture content of the foods. Nuts, cereals/beans, snacks, and spices were ground without freeze-drying. Beverages were analyzed in their original liquid form. Commercial infant foods were purchased from local grocery stores and were freeze-dried before analysis. The concentration data are based on the original wet weight. Foods were extracted and purified according to a published method (9,10). All samples were analyzed in duplicate.
HPLC-MS/MS analyses. Analysis and quantification methods were described (9,10). Catechin glycoside and epicatechin glycoside, which were detected in some foods, were quantified as monomers. The quantification limits (signal-to-noise ratio = 10) of our method ranged from 0.076 to 0.191 ng (injection on column) for the individual oligomers and the polymers. The relative SD of the quantification was 4.2% for total PAs and 7.9 ± 3.4% for individual oligomers in a control blueberry sample (n = 38).
Estimation of PA intakes. The daily intake of PAs was estimated using data from the USDAs Continuing Survey of Food Intakes by Individuals (CSFII) of 19941996: mean quantities of common foods consumed per person per day (11). The mean daily intake of PAs by infants was estimated on the basis of the recommendations of the American Academy of Pediatrics (12), which were detailed as feeding guidelines by pediatricians for convenient use by parents (13).
| RESULTS |
|---|
|
|
|---|
|
Different types of PAs were found in various foods. The homogeneous B-type PCs, which consist of catechin and/or epicatechin as constituent units, were detected as the exclusive PAs in 20 kinds of foods (Table 1). Another seven kinds of foods also contained exclusively PCs. However, a small fraction of PCs in those foods contained A-type linkages or gallic acid esters. In addition to the PCs, PPs and PDs were detected as minor components in various foods.
PA-containing ingredients have been used in complementary infant foods. PA concentrations in commercial infant foods were also determined (see supplemental data).5 Because the consumption survey for complementary infant foods is not available, the mean intake of PAs by infants was estimated on the basis of the recommendations of the American Academy of Pediatrics (12). The estimations were also based on the results of our survey, which indicates that 25% of infant cereals, 90% of infant juices, and 85% of fruit-based infant foods contain PAs. According to the feeding guidelines (13), complementary infant feeding starts with infant cereals and juice for infants 46 mo of age with a recommended median serving amount of 12.5 g/d or 90 mL/d. Infant foods based on fruits are introduced after 6 mo. The recommended median serving amounts are 35 g of cereal, 125 mL of juice, and 100 g of cooked/mashed fruits per day. Assuming that there is no preference in the selection of the foods, the daily intake of PAs was estimated to be 1.3 mg/d for infants 46 mo old and 26.9 mg/d for infants 6-10 mo old.
The mean daily PA intakes of different age and gender groups in the United States were estimated and are shown in Table 2. The mean daily intake of PAs in the population of all ages (>2 y old) in the United States is estimated to be 53.6 mg/person excluding the monomers, or 57.7 mg/person including the monomers. Of the PAs ingested,
73.9% have a DP >3. Raw apple is the major contributor to dietary PA intake (32.0%), followed by chocolate (17.9%) and grapes (17.8%). The PA intake in different age and gender groups varies. The 25 and 611 y old age groups and men >60 y old consumed more PAs than other groups because they included more fruits, especially apple, in their diet. The intake of PAs by adolescents was below the mean value.
|
| DISCUSSION |
|---|
|
|
|---|
PAs in foods cover a wide range of DP values. We presented the concentrations of monomers, dimers, and trimers separately because recent studies suggested that these low-molecular-weight PA oligomers (DP
3) could be absorbed intact in the gastrointestinal tract. Déprez et al. (14) demonstrated that (+)-catechin and PA dimers and trimers were permeable through the Caco-2 human intestinal cell line. The permeability of a PA polymer with a mean DP of 6 was
10 times lower, suggesting that PA dimers and trimers could be absorbed in vivo and that polymers could not. Absorption of the dimers was confirmed by detection of PC B5 in human blood after the subjects consumed PC-rich chocolate (15).
We presented the concentration of all PAs with DP > 3 collectively in 3 groups because similarities in their absorption mode have been postulated. Unlike the lower oligomers, PAs with DP > 3 appear not to be absorbed directly from the gastrointestinal lumen (14) but are thought to depolymerize into mixtures of epicatechin monomer and dimers in the acidic environment of the stomach. The resultant monomers and dimers were absorbed in the small intestine (16). Our observation in pigs showed that depolymerization of ingested polymers (DP > 10) was not significant in the stomach 4 h after eating (Gu and Prior, unpublished data). It was suggested that the majority of PAs transit into the small intestine intact (17) and are degraded mainly by colonic microflora in the cecum and large intestine. Déprez et al. (18) reported that incubation of polymeric PCs with human colonic microflora in vitro in anoxic conditions completely degraded the PCs after 48 h. The degradation products included phenylacetic, phenylpropionic, and phenylvaleric acids. These phenolic acids have been suggested to be the major metabolites of oligomeric and polymeric PAs in healthy humans (19).
Epidemiologic studies suggested an association between ingestion of polyphenols, especially flavonoids, and the prevention of diseases. Many authors have estimated the daily intake of flavonoids based on food composition and consumption survey data. Estimated data from several countries are largely consistent. The overall flavonoid (flavonols and flavones) intake in a population of women in the United States was estimated recently to be 24.6 ± 18.5 mg/d, with quercetin as the major contributor (70.2%) (4). The mean intake of flavonoid (including flavonols, flavones, and flavanones) was estimated to be 24.2 ± 26.7, 28.6 ± 12.3, and 25.9 mg/d in the populations of Finland, Denmark, and the Netherlands, respectively (57). However, these authors did not include monomeric, oligomeric, and polymeric flavan-3-ols in their estimation. Apples have been identified as a major dietary source of flavonoids in epidemiologic studies. The concentration of flavonoids other than PAs in fresh apples was determined to be 5.3 mg/100 g (3). The concentrations of PAs in various cultivars of apples were determined in our study to be in a range of 69.6141.0 mg/100 g. Thus, the total flavonoid content in apples used in previous studies was significantly lower than the actual value. A similar situation may exist for other foods that contain PAs. As a result, underestimation of the total flavonoid intakes could be enormous.
Flavan-3-ol monomers are considered to be different from PAs by definition. Their ingestion was studied previously. Tea is known as a major source of flavan-3-ol monomers (and oxidative derivatives) but not an important source of PAs, because few PAs have been detected in green leaves (20,21). Arts et al. (22) estimated that the mean intake of flavan-3-ol monomers in the Netherlands was 50 mg/d, with tea as the major contributor (65.287.3%) followed by chocolate and apple. He also pointed out that the mean daily intake of flavan-3-ol monomers in the United States should be lower than that in Denmark. The daily intakes of flavan-3-ol monomers from tea were estimated to be in the range of 12.734.2 mg/person for adults in the United States based on the data of Lakenbrink et al. (20). The total daily intake of flavan-3-ol monomers is estimated to be 17.138.6 mg/person for adults in the United States after flavan-3-ols from other foods (Table 1) are included. The mean daily intake of oligomeric and polymeric PAs (53.6 mg/person, Table 2) is higher than that of monomeric flavan-3-ols, and is twice as high as the combined overall intake of other flavonoids, which include flavonols, flavones, and flavanones. Based on these discussions, we conclude that PAs are the major flavonoids ingested in Western diets.
Complementary infant foods are necessary to meet increasing nutritional needs and for weaning. The mean daily intake of PAs for infants 610 mo old is estimated to be 3.1 mg/kg body weight, which is four times higher than the mean daily intake in adults of >20 y old (0.77 mg/kg body weight). Information concerning the influence of such high intake of PAs or other phytochemicals on the health and growth of infants is scarce. Increasing evidence suggests that exposure to these nutrients in early infancy may have long-term effects in later life (23).
In conclusion, this study demonstrates that many foods contain substantial amounts of PAs. PAs in these foods are different in terms of concentration, distribution of oligomers and polymers, constituent flavan-3-ol units, and interflavan linkages. PAs account for a major fraction of the total flavonoids ingested in Western diets. PAs should be taken into account when studying the epidemiologic association between flavonoid intake and chronic diseases. This study provided the first opportunity to examine this association.
| FOOTNOTES |
|---|
2 Mention of a trade name, proprietary product or specific equipment does not constitute endorsement by the U.S. Department of Agriculture. ![]()
4 Abbreviations used: DP, degree of polymerization; PAs, proanthocyanidins; PCs, procyanidins; PDs, prodelphinidins; PPs, propelargonidins. ![]()
5 A list of foods containing no detectable proanthocyanidins and concentrations of proanthocyanidins in infant foods is provided as supplemental data in the online posting of this paper at http://www.nutrition.org. ![]()
Manuscript received 2 October 2003. Initial review completed 11 November 2003. Revision accepted 1 December 2003.
| LITERATURE CITED |
|---|
|
|
|---|
1. Porter, L. J. (1994) Flavans and proanthocyanidins. Harbone, J. B. eds. The Flavonoids 1994:23-53 Chapman & Hall London, UK. .
2. Santos-Buelga, C. & Scalbert, A. (2000) Proanthocyanidins and tannin-like compounds-nature, occurrence, dietary intake and effects on nutrition and health. J. Sci. Food Agric. 80:1094-1117.
3. Mattila, P., Astola, J. & Kumpulainen, J. T. (2000) Determination of flavonoids in plant material by HPLC with diode-array and electro-array detections. J. Agric. Food Chem. 48:5834-5841.[Medline]
4. Sesso, H. D., Gaziano, J. M., Liu, S. & Buring, J. E. (2003) Flavonoid intake and the risk of cardiovascular disease in women. Am. J. Clin. Nutr. 77:1400-1408.
5. Knekt, P., Kumpulainen, J., Jarvinen, R., Rissanen, H., Heliovaara, M., Reunanen, A., Hakulinen, T. & Aromaa, A. (2002) Flavonoid intake and risk of chronic diseases. Am. J. Clin. Nutr. 76:560-568.
6. Geleijnse, J. M., Launer, L. J., Van der Kuip, D. A., Hofman, A. & Witteman, J. C. (2002) Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am. J. Clin. Nutr. 75:880-886.
7. Hertog, M. G., Feskens, E. J., Hollman, P. C., Katan, M. B. & Kromhout, D. (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342:1007-1011.[Medline]
8. Hammerstone, J. F., Lazarus, S. A. & Schmitz, H. H. (2000) Procyanidin content and variation in some commonly consumed foods. J. Nutr. 130:2086S-2092S.
9. Gu, L., Kelm, M., Hammerstone, J. F., Beecher, G., Cunningham, D., Vannozzi, S. & Prior, R. L. (2002) Fractionation of polymeric procyanidins from lowbush blueberry and quantification of procyanidins in selected foods with an optimized normal-phase HPLC-MS fluorescent detection method. J. Agric. Food Chem. 50:4852-4860.[Medline]
10. Gu, L., Kelm, M. A., Hammerstone, J. F., Beecher, G., Holden, J., Haytowitz, D. & Prior, R. L. (2003) Screening of foods containing proanthocyanidins and their structural characterization using LC-MS/MS and thiolytic degradation. J. Agric. Food Chem. 51:7513-7521.[Medline]
11. USDA, ARS () The 19941996 Continuing Survey of Food Intakes by Individuals: Foods Commonly Eaten in the United States: Quantities Consumed Per Eating Occasion and in a Day. http://www.barc.usda.gov/bhnrc/foodsurvey/pdf/Portion.pdf. (Accessed July 16, 2003.).
12. American Academy of Pediatrics (1998) Kleinman, R. E. eds. Pediatric Nutrition Handbook 4th ed. 1998:43-53 Elk Grove Village, IL. .
13. Hendricks, K. M. (2003) Weaning: pathophysiology, practice, and policy. Walker, W. A. Watkin, J. B. Duggan, C. eds. Nutrition in pediatrics: basic science and clinical applications 2003:528-538 BC Decker Hamilton, Canada. .
14. Déprez, S., Mila, I., Huneau, J. F., Tome, D. & Scalbert, A. (2001) Transport of proanthocyanidin dimer, trimer, and polymer across monolayers of human intestinal epithelial Caco-2 cells. Antioxid. Redox Signal. 3:957-967.[Medline]
15. Holt, R. R., Lazarus, S. A., Sullards, M. C., Zhu, Q. Y., Schramm, D. D., Hammerstone, J. F., Fraga, C. G., Schmitz, H. H. & Keen, C. L. (2002) Procyanidin dimer B2 [epicatechin-(4beta-8)-epicatechin] in human plasma after the consumption of a flavanol-rich cocoa. Am. J. Clin. Nutr. 76:798-804.
16. Spencer, J. P., Chaudry, F., Pannala, A. S., Srai, S. K., Debnam, E. & Rice-Evans, C. (2000) Decomposition of cocoa procyanidins in the gastric milieu. Biochem. Biophys. Res. Commun. 272:236-241.[Medline]
17. Rios, L. Y., Bennett, R. N., Lazarus, S. A., Remesy, C., Scalbert, A. & Williamson, G. (2002) Cocoa procyanidins are stable during gastric transit in humans. Am. J. Clin. Nutr. 76:1106-1110.
18. Déprez, S., Brezillon, C., Rabot, S., Philippe, C., Mila, I., Lapierre, C. & Scalbert, A. (2000) Polymeric proanthocyanidins are catabolized by human colonic microflora into low-molecular-weight phenolic acids. J. Nutr. 130:2733-2738.
19. Rios, L. Y., Gonthier, M. P., Remesy, C., Mila, I., Lapierre, C., Lazarus, S. A., Williamson, G. & Scalbert, A. (2003) Chocolate intake increases urinary excretion of polyphenol-derived phenolic acids in healthy human subjects. Am. J. Clin. Nutr. 77:912-918.
20. Lakenbrink, C., Lapczynski, S., Maiwald, B. & Engelhardt, U. H. (2000) Flavonoids and other polyphenols in consumer brews of tea and other caffeinated beverages. J. Agric. Food Chem. 48:2848-2852.[Medline]
21. Lakenbrink, C., Engelhardt, U. H. & Wray, V. (1999) Identification of two novel proanthocyanidins in green tea. J. Agric. Food Chem. 47:4621-4624.[Medline]
22. Arts, I. C., Hollman, P. C., Feskens, E. J., Bueno de Mesquita, H. B. & Kromhout, D. (2001) Catechin intake and associated dietary and lifestyle factors in a representative sample of Dutch men and women. Eur. J. Clin. Nutr. 55:76-81.[Medline]
23. Lucas, A. (1998) Programming by early nutrition: an experimental approach. J. Nutr. 128:401S-406S.
This article has been cited by other articles:
![]() |
J. Balzer, T. Rassaf, C. Heiss, P. Kleinbongard, T. Lauer, M. Merx, N. Heussen, H. B. Gross, C. L. Keen, H. Schroeter, et al. Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients a double-masked, randomized, controlled trial. J. Am. Coll. Cardiol., June 3, 2008; 51(22): 2141 - 2149. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Ovaskainen, R. Torronen, J. M. Koponen, H. Sinkko, J. Hellstrom, H. Reinivuo, and P. Mattila Dietary Intake and Major Food Sources of Polyphenols in Finnish Adults J. Nutr., March 1, 2008; 138(3): 562 - 566. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Datla, V. Zbarsky, D. Rai, S. Parkar, N. Osakabe, O. I. Aruoma, and D. T. Dexter Short-Term Supplementation with Plant Extracts Rich in Flavonoids Protect Nigrostriatal Dopaminergic Neurons in a Rat Model of Parkinson's Disease J. Am. Coll. Nutr., August 1, 2007; 26(4): 341 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Prior, L. Gu, X. Wu, R. A. Jacob, G. Sotoudeh, A. A. Kader, and R. A. Cook Plasma Antioxidant Capacity Changes Following a Meal as a Measure of the Ability of a Food to Alter In Vivo Antioxidant Status J. Am. Coll. Nutr., April 1, 2007; 26(2): 170 - 181. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Erdman Jr., D. Balentine, L. Arab, G. Beecher, J. T. Dwyer, J. Folts, J. Harnly, P. Hollman, C. L. Keen, G. Mazza, et al. Flavonoids and Heart Health: Proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC J. Nutr., March 1, 2007; 137(3): 718S - 737S. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Brat, S. George, A. Bellamy, L. D. Chaffaut, A. Scalbert, L. Mennen, N. Arnault, and M. J. Amiot Daily Polyphenol Intake in France from Fruit and Vegetables J. Nutr., September 1, 2006; 136(9): 2368 - 2373. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Buijsse, E. J. M. Feskens, F. J. Kok, and D. Kromhout Cocoa intake, blood pressure, and cardiovascular mortality: the zutphen elderly study. Arch Intern Med, February 27, 2006; 166(4): 411 - 417. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||